
|Articles|November 1, 2004
Intensive post-Tx cancer surveillance often unneeded
San Francisco-Urologists need to become more frugal in monitoring patients after urologic cancer treatment, advises Steven C. Campbell, MD, PhD, associate professor and co-director of urologic oncology at Loyola University Medical Center, Maywood, IL.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Elizabeth Nally, MBBS, on decision regret and toxicity perception with adjuvant pembrolizumab
2
Neil Baum, MD, and Abraham Morgentaler, MD, discuss the history of testosterone and prostate cancer
3
Published data show rPFS benefit with lutetium Lu 177 vipivotide tetraxetan in mHSPC
4
Optimizing care for men with overactive bladder, with Keith Xavier, MD
5






